GMO Beyond China ETF
BCHI
5 hedge funds and large institutions have $3.35M invested in GMO Beyond China ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
43.05% more ownership
Funds ownership: 0% → 43.05% (+43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$2.18M |
| 2 |
HC
Hara Capital
Bellevue,
Washington
|
+$499K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$418K |
| 4 |
Jane Street
New York
|
+$306K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$593 |
Top Sellers
BCHI Hedge Fund Activity: Q1 2025 in Review
5 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q1 2025, worth a combined $3.35M.
Buyers outnumbered sellers: 5 funds opened new BCHI positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cresset Asset Management, opening a new position worth an estimated $2.18M.
- 5 institutional investors held GMO Beyond China ETF (BCHI) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $3.35M of GMO Beyond China ETF stock for Q1 2025.
- 5 funds opened new GMO Beyond China ETF positions in Q1 2025 and 0 closed out, a net change of +5 holders.
- The largest GMO Beyond China ETF buyer in Q1 2025 was Cresset Asset Management, an estimated $2.18M added.
Based on aggregated 13F filings for Q1 2025.